Team:DTU-Denmark-2/Our Partners/Sponsors

From 2011.igem.org

(Difference between revisions)
Line 46: Line 46:
<a href="http://www.alk-abello.com" target="_blank"><img src="https://static.igem.org/mediawiki/2011/0/0c/Alk_Logo.jpg" with="80px"height="80px"alt=""" class="centered"/>  </a>
<a href="http://www.alk-abello.com" target="_blank"><img src="https://static.igem.org/mediawiki/2011/0/0c/Alk_Logo.jpg" with="80px"height="80px"alt=""" class="centered"/>  </a>
<p align="justify">
<p align="justify">
-
ALK is the world leader in allergy vaccination. The treatment is recognized by the World Health Organization (WHO) as the only treatment that can change the underlying allergic disease.
+
ALK was established in the beginning of the 1920'ies first as a part of a pharmacy and then later it became a independent company. ALK's main focus are on the prevention, diagnosis and treatment of allergies and are a global leading company in allergy vaccinations. ALK's research are ground breaking and one of ALK's treatments are recognized by WHO as the only treatment that can change the underlying allergic disease.
 +
 
</p>
</p>

Revision as of 09:00, 8 September 2011



Sponsors

Novozymes is a Danish biotech companny and one of the world leading in production and discovery of new enzymes.

Bavarian Nordic is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need.

ALK was established in the beginning of the 1920'ies first as a part of a pharmacy and then later it became a independent company. ALK's main focus are on the prevention, diagnosis and treatment of allergies and are a global leading company in allergy vaccinations. ALK's research are ground breaking and one of ALK's treatments are recognized by WHO as the only treatment that can change the underlying allergic disease.

Novo Nordisk already toke it's origin in 1922 and after fusion of the two companies in 1989, it became fast growing and a global healthcare company with many years of innovation and leadership in diabetes care. Novo Nordisk also has leading research within haemophilia care, growth hormone therapy and hormone replacement therapy.

DNA Technologies was established in 1992 and are today among the leading manufactures and suppliers of costume designed oligonucleotides. Besides the manufactory of oligoneucleotides, DNA technology provide a wide range of different services for the costumers including DNA sequencing and distribution of molecular bioagents.

Integrated DNA technology was established in 1987 and are among the leading manufactures and developers in the research field of biotechnology and pharmaceuticals. IDT is recognized as the industry leader in manufacturing oligonucleotides due to their compatibility in analytic sophistication, design engineering, costume support, information technology and with day to day delivery.

Pharmadanmark was established in 1873 and is a union gathering academics within the pharmaceutical field. Pharmadanmarks goal is to provide its members with the best conditions during and after graduation in the terms of professional development, employment, salary and career development. Additionally, Pharmadanmark also provide benefits to their members in form of cheap insurances, counseling, coaching and other financial support.